Leptomeningeal Carcinomatosis: Cerebral spinal fluid tumours

M. Stone
{"title":"Leptomeningeal Carcinomatosis: Cerebral spinal fluid tumours","authors":"M. Stone","doi":"10.21307/ajon-2017-128","DOIUrl":null,"url":null,"abstract":"Abstract Leptomeningeal Carcinomatosis (LC) is the dissemination of cancer, commonly breast, lung, melanoma, acute lymphoblastic leukaemia and Non-Hodgkin lymphoma occurring through either direct extension from surrounding tumours or metastasis of a preexisting, parenchymal central nervous system tumour. A rise in the diagnosis of leptomeningeal disease has been seen with increased survival rates of cancer due to improved medical treatment, with 5-8% of patients with cancer going on to develop LC. Leptomeningeal Carcinomatosis spreads to the meninges, the outer covering of the brain and spinal cord, directly migrating into the cerebral spinal fluid (CSF), arachnoid and pia mater. This migration of tumour cells occurs throughout the arachnoid vessels or choroid plexus into the surrounding outer layers extending into the CSF. On entry into the CSF, tumour cells are infiltrated in a diffuse or multifocal manner where the leptomeninges cover the surface of the brain and spinal cord. This covering causes the meninges to become irritated causing patients to exhibit signs of photophobia, neck stiffness, neurological decline and cranial nerve defects. LC has a significant morbidity and mortality rate with a median survival of 4-6 weeks if untreated and 2-3 months if treated. Diagnosis is based on analysis of the cerebral spinal fluid, through detection of positive cytology of LC tumour cells, elevated protein and CSF pressures. Magnetic resonance imaging findings identify areas of meningeal enhancement indicative of meningeal irritation. The neuroscience nurse role in the patient care includes providing a supportive environment and thorough assessment of vital and neurological signs. Treatment aims to improve or maintain a patient’s neurological status while prolonging survival and palliation. The literature review will highlight the diagnosis, progression and treatment for LC to further increase awareness and inform neuroscience nurses of increasing trends in management.","PeriodicalId":32533,"journal":{"name":"Australasian Journal of Neuroscience","volume":"18 1","pages":"11 - 14"},"PeriodicalIF":0.0000,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australasian Journal of Neuroscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21307/ajon-2017-128","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Leptomeningeal Carcinomatosis (LC) is the dissemination of cancer, commonly breast, lung, melanoma, acute lymphoblastic leukaemia and Non-Hodgkin lymphoma occurring through either direct extension from surrounding tumours or metastasis of a preexisting, parenchymal central nervous system tumour. A rise in the diagnosis of leptomeningeal disease has been seen with increased survival rates of cancer due to improved medical treatment, with 5-8% of patients with cancer going on to develop LC. Leptomeningeal Carcinomatosis spreads to the meninges, the outer covering of the brain and spinal cord, directly migrating into the cerebral spinal fluid (CSF), arachnoid and pia mater. This migration of tumour cells occurs throughout the arachnoid vessels or choroid plexus into the surrounding outer layers extending into the CSF. On entry into the CSF, tumour cells are infiltrated in a diffuse or multifocal manner where the leptomeninges cover the surface of the brain and spinal cord. This covering causes the meninges to become irritated causing patients to exhibit signs of photophobia, neck stiffness, neurological decline and cranial nerve defects. LC has a significant morbidity and mortality rate with a median survival of 4-6 weeks if untreated and 2-3 months if treated. Diagnosis is based on analysis of the cerebral spinal fluid, through detection of positive cytology of LC tumour cells, elevated protein and CSF pressures. Magnetic resonance imaging findings identify areas of meningeal enhancement indicative of meningeal irritation. The neuroscience nurse role in the patient care includes providing a supportive environment and thorough assessment of vital and neurological signs. Treatment aims to improve or maintain a patient’s neurological status while prolonging survival and palliation. The literature review will highlight the diagnosis, progression and treatment for LC to further increase awareness and inform neuroscience nurses of increasing trends in management.
脑膜轻脑膜癌:脑脊液肿瘤
轻脑膜癌(LC)是一种肿瘤的播散性疾病,常见于乳腺癌、肺癌、黑色素瘤、急性淋巴细胞白血病和非霍奇金淋巴瘤,其发生途径要么是周围肿瘤的直接扩散,要么是先前存在的实质中枢神经系统肿瘤的转移。随着医疗水平的提高,癌症患者的生存率也有所提高,而轻脑膜疾病的诊断率也有所上升,其中5-8%的癌症患者会发展为LC。脑膜轻脑膜癌扩散到脑膜,即大脑和脊髓的外层,直接迁移到脑脊液(CSF)、蛛网膜和硬脑膜。肿瘤细胞通过蛛网膜血管或脉络膜丛迁移到周围的外层,并延伸到脑脊液。进入脑脊液后,肿瘤细胞以弥漫性或多灶性浸润,其中轻脑膜覆盖脑和脊髓表面。这种覆盖导致脑膜受到刺激,导致患者表现出畏光、颈部僵硬、神经衰退和颅神经缺陷的迹象。LC具有显著的发病率和死亡率,如果不治疗,中位生存期为4-6周,如果治疗,中位生存期为2-3个月。诊断是基于对脑脊液的分析,通过检测LC肿瘤细胞阳性细胞学,升高的蛋白质和脑脊液压力。磁共振成像结果确定脑膜增强区域表明脑膜刺激。神经科学护士在病人护理中的作用包括提供一个支持性的环境和对生命体征和神经体征的全面评估。治疗的目的是改善或维持病人的神经系统状态,同时延长生存期和缓解。文献综述将强调LC的诊断、进展和治疗,以进一步提高认识,并告知神经科学护士管理的增长趋势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
5
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书